This is a preprint.
Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling in vitro
- PMID: 40950422
- PMCID: PMC12424891
- DOI: 10.1101/2025.01.24.25321071
Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling in vitro
Update in
-
Gene-Environment Interaction Affects Risk of Atopic Eczema: Population and In Vitro Studies.Allergy. 2025 Aug;80(8):2201-2212. doi: 10.1111/all.16605. Epub 2025 Jun 4. Allergy. 2025. PMID: 40462597 Free PMC article.
Abstract
Background: Environmental factors play a role in the pathogenesis of complex traits including atopic eczema (AE) and a greater understanding of gene-environment interactions (G*E) is needed to define pathomechanisms for disease prevention. We analysed data from 16 European studies to test for interaction between the 24 most significant AE-associated loci identified from genome-wide association studies and 18 early-life environmental factors. We tested for replication using a further 10 studies and in vitro modelling to independently assess findings.
Results: The discovery analysis showed suggestive evidence for interaction (p<0.05) between 7 environmental factors (antibiotic use, cat ownership, dog ownership, breastfeeding, elder sibling, smoking and washing practices) and at least one established variant for AE, 14 interactions in total (maxN=25,339). In replication analysis (maxN=252,040) dog exposure*rs10214237 (on chromosome 5p13.2 near IL7R) was nominally significant (ORinteraction=0.91 [0.83-0.99] P=0.025), with a risk effect of the T allele observed only in those not exposed to dogs. A similar interaction with rs10214237 was observed for siblings in the discovery analysis (ORinteraction=0.84[0.75-0.94] P=0.003), but replication analysis was under-powered ORinteraction=1.09[0.82-1.46]). Rs10214237 homozygous risk genotype is associated with lower IL-7R expression in human keratinocytes, and dog exposure modelled in vitro showed a differential response according to rs10214237 genotype.
Conclusions: Interaction analysis and functional assessment provide evidence that early-life dog exposure may modify the genetic effect of rs10214237 on AE via IL7R, supporting observational epidemiology showing a protective effect for dog ownership. The lack of evidence for other G*E studied here implies that only weak effects are likely to occur.
Keywords: Atopic eczema; atopic dermatitis; dog; environment; epidemiology; genetic; interaction; sibling.
Conflict of interest statement
SJB has received research funding (but no personal financial benefits) from the Wellcome Trust (220875/Z/20/Z), UKRI, Medical Research Council, Rosetrees Trust, Stoneygates Trust, British Skin Foundation, Charles Wolfson Charitable Trust, anonymous donations from people with eczema, Unilever, Pfizer, Abbvie, Sosei-Heptares, Janssen, European Lead Factory (which includes multiple industry partners). SJB, AB-A, KB, ADI, GHK, CS, SML and LP have received funding from the BIOMAP-IMI consortium (EU H2020 project ref No 821511) which receives support from several pharmaceutical industry partners. LP has received honorarium payment for a scientific talk on eczema genetics from LEO Pharma. GHK reports grants from the Netherlands Lung Foundation, ZON-MW, Ubbo Emmius Foundation, TEVA the Netherlands, GSK, Vertex, outside the submitted work (money to institution). His institution received compensation for consultancy or lectures from Astra Zeneca, Boehringer Ingelheim and Sanofi.
Figures
References
-
- Johansson S, Bieber T, Dahl R, Friedmann P, Lanier B, Lockey R, Motala C, Ortega Martell J, Platts-Mills T, Ring J, et al. : Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832–836. - PubMed
-
- Mehrmal S, Uppal P, Giesey RL, Delost GR: Identifying the prevalence and disability-adjusted life years of the most common dermatoses worldwide. J Am Acad Dermatol 2020, 82:258–259. - PubMed
-
- Langan SM, Irvine AD, Weidinger S: Atopic dermatitis. Lancet 2020, 396:345–360. - PubMed
-
- Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009, 124:1251–1258 e1223. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous